Control of cell growth by the SCF and APC/C ubiquitin ligases

Current Opinion in Cell Biology

Volumn 21, Issue 6, 2009, Pages 816-824

  Skaar, Jeffrey R ^b   Pagano, Michele ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHASE PROMOTING COMPLEX; NEDD8 PROTEIN; UBIQUITIN PROTEIN LIGASE;

CELL CYCLE REGULATION; CELL GROWTH; CONFORMATIONAL TRANSITION; ENZYME SUBSTRATE; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; UBIQUITINATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CULLIN PROTEINS; HUMANS; MODELS, BIOLOGICAL; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN; UBIQUITIN C; UBIQUITIN-PROTEIN LIGASES;

EID: 70549105793     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2009.08.004     Document Type: Review

References (73)

1. Pickart C.M., and Fushman D. Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol 8 (2004) 610-616
2. Hershko A., and Ciechanover A. The ubiquitin system. Annu Rev Biochem 67 (1998) 425-479
3. Schwartz A.L., and Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50 (1999) 57-74
4. Weissman A.M. Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2 (2001) 169-178
5. Cardozo T., and Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 5 (2004) 739-751
6. Nakayama K.I., and Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 6 (2006) 369-381
7. Petroski M.D., and Deshaies R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6 (2005) 9-20
8. Skaar J.R., Florens L., Tsutsumi T., Arai T., Tron A., Swanson S.K., Washburn M.P., and DeCaprio J.A. PARC and CUL7 form atypical cullin RING ligase complexes. Cancer Res 67 (2007) 2006-2014
9. Acquaviva C., and Pines J. The anaphase-promoting complex/cyclosome: APC/C. J Cell Sci 119 (2006) 2401-2404
10. Peters J.M. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 7 (2006) 644-656
11. Jin J., Cardozo T., Lovering R.C., Elledge S.J., Pagano M., and Harper J.W. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev 18 (2004) 2573-2580
12. Ang X.L., and Harper J.W. Interwoven ubiquitination oscillators and control of cell cycle transitions. Sci STKE 2004 (2004) pe31
13. Pan Z.Q., Kentsis A., Dias D.C., Yamoah K., and Wu K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23 (2004) 1985-1997
14. Rabut G., and Peter M. Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep 9 (2008) 969-976
15. Wei N., Serino G., and Deng X.W. The COP9 signalosome: more than a protease. Trends Biochem Sci 33 (2008) 592-600. This review provides an excellent introduction to the COP9 signalosome, an important regulator of cullin neddylation that was not addressed by this review owing to space constraints.
16. Soucy T.A., Smith P.G., Milhollen M.A., Berger A.J., Gavin J.M., Adhikari S., Brownell J.E., Burke K.E., Cardin D.P., Critchley S., et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458 (2009) 732-736. This report not only illustrates the role of CRLs in growth control but also suggests that NEDD8 inhibitors are clinically viable chemotherapeutics.
17. Goldenberg S.J., Cascio T.C., Shumway S.D., Garbutt K.C., Liu J., Xiong Y., and Zheng N. Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases. Cell 119 (2004) 517-528
18. Liu J., Furukawa M., Matsumoto T., and Xiong Y. NEDD8 modification of CUL1 dissociates p120(CAND1), an inhibitor of CUL1-SKP1 binding and SCF ligases. Mol Cell 10 (2002) 1511-1518
19. Zheng J., Yang X., Harrell J.M., Ryzhikov S., Shim E.H., Lykke-Andersen K., Wei N., Sun H., Kobayashi R., and Zhang H. CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex. Mol Cell 10 (2002) 1519-1526
20. Oshikawa K., Matsumoto M., Yada M., Kamura T., Hatakeyama S., and Nakayama K.I. Preferential interaction of TIP120A with Cul1 that is not modified by NEDD8 and not associated with Skp1. Biochem Biophys Res Commun 303 (2003) 1209-1216
21. Chuang H.W., Zhang W., and Gray W.M. Arabidopsis ETA2, an apparent ortholog of the human cullin-interacting protein CAND1, is required for auxin responses mediated by the SCF(TIR1) ubiquitin ligase. Plant Cell 16 (2004) 1883-1897
22. Furukawa M., Zhang Y., McCarville J., Ohta T., and Xiong Y. The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1. Mol Cell Biol 20 (2000) 8185-8197
23. Podust V.N., Brownell J.E., Gladysheva T.B., Luo R.S., Wang C., Coggins M.B., Pierce J.W., Lightcap E.S., and Chau V. A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc Natl Acad Sci U S A 97 (2000) 4579-4584
24. Read M.A., Brownell J.E., Gladysheva T.B., Hottelet M., Parent L.A., Coggins M.B., Pierce J.W., Podust V.N., Luo R.S., Chau V., et al. Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol 20 (2000) 2326-2333
25. Wu K., Chen A., and Pan Z.Q. Conjugation of Nedd8 to CUL1 enhances the ability of the ROC1-CUL1 complex to promote ubiquitin polymerization. J Biol Chem 275 (2000) 32317-32324
26. Morimoto M., Nishida T., Honda R., and Yasuda H. Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1). Biochem Biophys Res Commun 270 (2000) 1093-1096
27. Zheng N., Schulman B.A., Song L., Miller J.J., Jeffrey P.D., Wang P., Chu C., Koepp D.M., Elledge S.J., Pagano M., et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416 (2002) 703-709. The crystal structure presented in this study is a landmark in the study of the SCF complex. Although the structure is now understood to represent an inactive, closed form, it is still the most complete SCF structure, giving valuable architectural information. Additionally, it introduces key questions about SCF complex-mediated ubiquitination that led to the more recent structural studies of NEDD8-conjugated cullins.
28. Saha A., and Deshaies R.J. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol Cell 32 (2008) 21-31. This study offers an extremely detailed biochemical dissection of SCF complex-mediated ubiquitination.
29. Kawakami T., Chiba T., Suzuki T., Iwai K., Yamanaka K., Minato N., Suzuki H., Shimbara N., Hidaka Y., Osaka F., et al. NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J 20 (2001) 4003-4012
30. Duda D.M., Borg L.A., Scott D.C., Hunt H.W., Hammel M., and Schulman B.A. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 134 (2008) 995-1006. This important study reveals the structural nature of NEDD8 conjugation's stimulation of CRL function, which also solves several mechanistic questions posed by the original SCF complex structure.
31. Kamura T., Maenaka K., Kotoshiba S., Matsumoto M., Kohda D., Conaway R.C., Conaway J.W., and Nakayama K.I. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 18 (2004) 3055-3065
32. Huang D.T., Ayrault O., Hunt H.W., Taherbhoy A.M., Duda D.M., Scott D.C., Borg L.A., Neale G., Murray P.J., Roussel M.F., et al. E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol Cell 33 (2009) 483-495
33. Yu H. Cdc20: a WD40 activator for a cell cycle degradation machine. Mol Cell 27 (2007) 3-16
34. Li M., and Zhang P. The function of APC/CCdh1 in cell cycle and beyond. Cell Div 4 (2009) 2
35. Musacchio A., and Salmon E.D. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8 (2007) 379-393
36. Nilsson J., Yekezare M., Minshull J., and Pines J. The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. Nat Cell Biol 10 (2008) 1411-1420. This report demonstrates that APC/C is both a target and an effector of the spindle assembly checkpoint.
37. Ge S., Skaar J.R., and Pagano M. APC/C- and Mad2-mediated degradation of Cdc20 during spindle checkpoint activation. Cell Cycle 8 (2009) 167-171
38. Pan J., and Chen R.H. Spindle checkpoint regulates Cdc20p stability in Saccharomyces cerevisiae. Genes Dev 18 (2004) 1439-1451
39. Garcia-Higuera I., Manchado E., Dubus P., Canamero M., Mendez J., Moreno S., and Malumbres M. Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat Cell Biol 10 (2008) 802-811. In addition to demonstrating a role for Cdh1 in maintaining genome stability, this study also provides evidence that Cdh1 probably functions as a tumor suppressor. Somewhat surprisingly, Cdh1 function is not essential for mouse development.
40. Li M., Shin Y.H., Hou L., Huang X., Wei Z., Klann E., and Zhang P. The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory. Nat Cell Biol 10 (2008) 802-811
41. Sudo T., Ota Y., Kotani S., Nakao M., Takami Y., Takeda S., and Saya H. Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells. EMBO J 20 (2001) 6499-6508
42. Bassermann F., Frescas D., Guardavaccaro D., Busino L., Peschiaroli A., and Pagano M. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell 134 (2008) 256-267
43. Watanabe N., Arai H., Nishihara Y., Taniguchi M., Hunter T., and Osada H. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFβ-TRCP. Proc Natl Acad Sci U S A 101 (2004) 4419-4424
44. Peschiaroli A., Dorrello N.V., Guardavaccaro D., Venere M., Halazonetis T., Sherman N.E., and Pagano M. SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol Cell 23 (2006) 319-329
45. Mailand N., Bekker-Jensen S., Bartek J., and Lukas J. Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol Cell 23 (2006) 307-318
46. Mamely I., van Vugt M.A., Smits V.A., Semple J.I., Lemmens B., Perrakis A., Medema R.H., and Freire R. Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery. Curr Biol 16 (2006) 1950-1955
47. Jin L., Williamson A., Banerjee S., Philipp I., and Rape M. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 133 (2008) 653-665
48. Kirkpatrick D.S., Hathaway N.A., Hanna J., Elsasser S., Rush J., Finley D., King R.W., and Gygi S.P. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat Cell Biol 8 (2006) 700-710
49. Frescas D., and Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and β-TRCP: tipping the scales of cancer. Nat Rev Cancer 8 (2008) 438-449
50. Welcker M., and Clurman B.E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8 (2008) 83-93
51. Akhoondi S., Sun D., von der Lehr N., Apostolidou S., Klotz K., Maljukova A., Cepeda D., Fiegl H., Dafou D., Marth C., et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 67 (2007) 9006-9012
52. Tsunematsu R., Nakayama K., Oike Y., Nishiyama M., Ishida N., Hatakeyama S., Bessho Y., Kageyama R., Suda T., and Nakayama K.I. Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. J Biol Chem 279 (2004) 9417-9423
53. Thompson B.J., Jankovic V., Gao J., Buonamici S., Vest A., Lee J.M., Zavadil J., Nimer S.D., and Aifantis I. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J Exp Med 205 (2008) 1395-1408. This report (and the subsequent reference) details the control of hematopoietic stems by Fbxw7.
54. Matsuoka S., Oike Y., Onoyama I., Iwama A., Arai F., Takubo K., Mashimo Y., Oguro H., Nitta E., Ito K., et al. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev 22 (2008) 986-991. This report (and the previous reference) details the control of hematopoietic stems by Fbxw7.
55. Tetzlaff M.T., Yu W., Li M., Zhang P., Finegold M., Mahon K., Harper J.W., Schwartz R.J., and Elledge S.J. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci U S A 101 (2004) 3338-3345
56. Onoyama I., Tsunematsu R., Matsumoto A., Kimura T., de Alboran I.M., Nakayama K., and Nakayama K.I. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 204 (2007) 2875-2888
57. Seki A., Coppinger J.A., Du H., Jang C.Y., Yates III J.R., and Fang G. Plk1- and β-TRCP-dependent degradation of Bora controls mitotic progression. J Cell Biol 181 (2008) 65-78
58. Macurek L., Lindqvist A., Lim D., Lampson M.A., Klompmaker R., Freire R., Clouin C., Taylor S.S., Yaffe M.B., and Medema R.H. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 455 (2008) 119-123
59. Seki A., Coppinger J.A., Jang C.Y., Yates J.R., and Fang G. Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 320 (2008) 1655-1658
60. Dorrello N.V., Peschiaroli A., Guardavaccaro D., Colburn N.H., Sherman N.E., and Pagano M. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314 (2006) 467-471
61. Dehan E., Bassermann F., Guardavaccaro D., Vasiliver-Shamis G., Cohen M., Lowes K.N., Dustin M., Huang D.C., Taunton J., and Pagano M. betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis. Mol Cell 33 (2009) 109-116
62. Guardavaccaro D., Kudo Y., Boulaire J., Barchi M., Busino L., Donzelli M., Margottin-Goguet F., Jackson P.K., Yamasaki L., and Pagano M. Control of meiotic and mitotic progression by the F box protein β-TRCP1 in vivo. Dev Cell 4 (2003) 799-812
63. Margottin-Goguet F., Hsu J.Y., Loktev A., Hsieh H.M., Reimann J.D., and Jackson P.K. Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev Cell 4 (2003) 813-826
64. Guardavaccaro D., Frescas D., Dorrello N.V., Peschiaroli A., Multani A.S., Cardozo T., Lasorella A., Iavarone A., Chang S., Hernando E., et al. Control of chromosome stability by the β-TRCP-REST-Mad2 axis. Nature 452 (2008) 365-369
65. Busino L., Donzelli M., Chiesa M., Guardavaccaro D., Ganoth D., Dorrello N.V., Hershko A., Pagano M., and Draetta G.F. Degradation of Cdc25A by β-TRCP during S phase and in response to DNA damage. Nature 426 (2003) 87-91
66. Jin J., Shirogane T., Xu L., Nalepa G., Qin J., Elledge S.J., and Harper J.W. SCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev 17 (2003) 3062-3074
67. Yen H.C., and Elledge S.J. Identification of SCF ubiquitin ligase substrates by global protein stability profiling. Science 322 (2008) 923-929
68. Yen H.C., Xu Q., Chou D.M., Zhao Z., and Elledge S.J. Global protein stability profiling in mammalian cells. Science 322 (2008) 918-923. This study introduces a method for measuring the stability of proteins on a global scale. The use of such methods in new screens for substrates of SCF complexes (see reference [67]) or other ubiquitin ligases may faciliate the future identification of substrates. Notably, GPS will probably not help in the identification of substrates for non-degradation types of ubiquitin modification.
69. Lin D.I., Barbash O., Kumar K.G., Weber J.D., Harper J.W., Klein-Szanto A.J., Rustgi A., Fuchs S.Y., and Diehl J.A. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol Cell 24 (2006) 355-366
70. Santra M.K., Wajapeyee N., and Green M.R. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459 (2009) 722-725
71. Wei S., Yang H.C., Chuang H.C., Yang J., Kulp S.K., Lu P.J., Lai M.D., and Chen C.S. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells. J Biol Chem 283 (2008) 26759-26770
72. Okabe H., Lee S.H., Phuchareon J., Albertson D.G., McCormick F., and Tetsu O. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PLoS ONE 1 (2006) e128
73. Yu Z.K., Gervais J.L., and Zhang H. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc Natl Acad Sci U S A 95 (1998) 11324-11329